Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders.

Audrey N JajoskyNathaniel P HavensNavid SadriKwadwo A OduroErika M MooreRose C BeckHoward J Meyerson

Published in: American journal of clinical pathology (2021)

Overall, implementation of this targeted lymphoid NGS panel as part of regular hematopathology practice was found to be a beneficial adjunct in the evaluation of low-grade LPDs.

Keyphrases

low grade
high grade
primary care
healthcare
cancer therapy
quality improvement
epstein barr virus
copy number
dna methylation
circulating tumor